A Pilot Study of Autologous Ex Vivo Activated NK Cell Infusion in the Treatment of Metastatic Nasopharyngeal Carcinoma
PHASE1CompletedINTERVENTIONAL
Timeline
Start Date
May 31, 2007
Conditions
Metastatic Nasopharyngeal
Interventions
DRUG
Interleukin, NK cells
Trial Locations (1)
Unknown
National University Hospital, Singapore
All Listed Sponsors
lead
National University Hospital, Singapore
OTHER
NCT00717184 - A Pilot Study of Autologous Ex Vivo Activated NK Cell Infusion in the Treatment of Metastatic Nasopharyngeal Carcinoma | Biotech Hunter | Biotech Hunter